215 related articles for article (PubMed ID: 32392629)
21. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
[TBL] [Abstract][Full Text] [Related]
22. Screening of a Novel Upregulated lncRNA, A2M-AS1, That Promotes Invasion and Migration and Signifies Poor Prognosis in Breast Cancer.
Fang K; Caixia H; Xiufen Z; Zijian G; Li L
Biomed Res Int; 2020; 2020():9747826. PubMed ID: 32352014
[TBL] [Abstract][Full Text] [Related]
23. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.
Jacobsen BM; Schittone SA; Richer JK; Horwitz KB
Mol Endocrinol; 2005 Mar; 19(3):574-87. PubMed ID: 15563544
[TBL] [Abstract][Full Text] [Related]
24. The clinical significance of circulating DSCAM-AS1 in patients with ER-positive breast cancer and construction of its competitive endogenous RNA network.
Moradi MT; Fallahi H; Rahimi Z
Mol Biol Rep; 2020 Oct; 47(10):7685-7697. PubMed ID: 33040318
[TBL] [Abstract][Full Text] [Related]
25. The emerging role of NR2F1-AS1 in the tumorigenesis and progression of human cancer.
Luo D; Liu Y; Yuan S; Bi X; Yang Y; Zhu H; Li Z; Ji L; Yu X
Pathol Res Pract; 2022 Jul; 235():153938. PubMed ID: 35552086
[TBL] [Abstract][Full Text] [Related]
26. Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker.
Torkashvand S; Basi A; Ajdarkosh H; Rakhshani N; Nafisi N; Mowla SJ; Moghadas A; Mohammadipour M; Karbalaie Niya MH
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2897-2902. PubMed ID: 34582659
[TBL] [Abstract][Full Text] [Related]
27. Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
Li XX; Wang LJ; Hou J; Liu HY; Wang R; Wang C; Xie WH
Biomed Res Int; 2020; 2020():8970340. PubMed ID: 32190687
[TBL] [Abstract][Full Text] [Related]
28. Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer.
Zhang Z; Yu W; Tang D; Zhou Y; Bi M; Wang H; Zheng Y; Chen M; Li L; Xu X; Zhang W; Tao H; Jin VX; Liu Z; Chen L
RNA Biol; 2020 Nov; 17(11):1590-1602. PubMed ID: 32506995
[TBL] [Abstract][Full Text] [Related]
29. BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
Liu D; Zhou K
Clin Breast Cancer; 2020 Feb; 20(1):41-50.e8. PubMed ID: 31547956
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.
Huang NS; Chi YY; Xue JY; Liu MY; Huang S; Mo M; Zhou SL; Wu J
Oncotarget; 2016 Jun; 7(25):37957-37965. PubMed ID: 27191888
[TBL] [Abstract][Full Text] [Related]
31. ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer.
Wang Z; Katsaros D; Biglia N; Shen Y; Loo L; Yu X; Lin H; Fu Y; Chu WM; Fei P; Ni Y; Jia W; Deng X; Qian B; Yu H
Breast Cancer Res Treat; 2019 Jun; 175(2):353-368. PubMed ID: 30830488
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.
Itoh M; Iwamoto T; Matsuoka J; Nogami T; Motoki T; Shien T; Taira N; Niikura N; Hayashi N; Ohtani S; Higaki K; Fujiwara T; Doihara H; Symmans WF; Pusztai L
Breast Cancer Res Treat; 2014 Jan; 143(2):403-9. PubMed ID: 24337596
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA
Li S; Zheng K; Pei Y; Wang W; Zhang X
Aging (Albany NY); 2019 Dec; 11(23):11609-11623. PubMed ID: 31801112
[TBL] [Abstract][Full Text] [Related]
34. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
35. FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PR + BRCA patients.
Ríos-Romero M; Cedro-Tanda A; Peña-Luna M; Mancera-Rodríguez MA; Hidalgo-Pérez L; Cisneros-Villanueva M; Beltrán-Anaya FO; Arellano-Llamas R; Jiménez-Morales S; Alfaro-Ruíz LA; Tenorio-Torres A; Domínguez-Reyes C; Villegas-Carlos F; Ochoa-Mendoza E; Hidalgo-Miranda A
Sci Rep; 2020 Aug; 10(1):14145. PubMed ID: 32839509
[TBL] [Abstract][Full Text] [Related]
36. HIF2-Induced Long Noncoding RNA RAB11B-AS1 Promotes Hypoxia-Mediated Angiogenesis and Breast Cancer Metastasis.
Niu Y; Bao L; Chen Y; Wang C; Luo M; Zhang B; Zhou M; Wang JE; Fang YV; Kumar A; Xing C; Wang Y; Luo W
Cancer Res; 2020 Mar; 80(5):964-975. PubMed ID: 31900259
[TBL] [Abstract][Full Text] [Related]
37. LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4.
Wang L; Zhao S; Mingxin YU
Pharmazie; 2019 May; 74(5):295-300. PubMed ID: 31109400
[TBL] [Abstract][Full Text] [Related]
38. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
[TBL] [Abstract][Full Text] [Related]
39. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
40. LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT.
Ren P; Zhang H; Chang L; Hong XD; Xing L
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3686-3693. PubMed ID: 32329844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
